Haorui Gene

Haorui Gene is a China-based clinical genomics company focused on blood typing genomics, HLA typing, blood group genotyping, and rare blood type identification. The company provides sequencing-based services and products for clinical laboratories, blood centers, and research institutions, with particular expertise in long-read sequencing applications for transfusion medicine and hematology. Haorui has built a commercial footprint in China and, in 2025, was appointed an official distributor for PacBio's Vega platform in China. Its business appears centered on clinical diagnostics support, genomics testing workflows, and related research services rather than development of therapeutic drugs. The company is best characterized as a commercial-stage genomics and diagnostic platform company serving precision medicine and transfusion-related applications.